Reyhan AYAZ BİLİR
(Medeniyet Üniversitesi, İstanbul, Türkiye)
İlayda LOÇLAR KARAALP
(Medeniyet Üniversitesi, İstanbul, Türkiye)
Yıl: 2020Cilt: 51Sayı: 3ISSN: 1300-7971 / 2148-4864Sayfa Aralığı: 165 - 167Türkçe

16 0
Gebelikte Tanı Konulan Budd-Chiari Sendromu Takip ve Yönetimi: Olgu Sunumu
Budd-Chiari (BCS) sendromu hepatik venöz kanın kalbe ulaşım yolunda obstrüksiyonu sonucu konjesyona bağlı kara-ciğer hasarına sebep olan gebelikte nadir rastlanan bir klinik tablodur. Etiyolojisinde gebelik, oral kontraseptif kullanımı, myeleoproliferatif hastalıklar, antifosfolipid antikor sendromu gibi tromboza eğilim yaratan altta yatan birçok hastalık mev-cuttur. BCS'li kadınlarda gebelik ve gebelik sonrası yönetim ve gebelik sonuçları hakkında yeterli veri bulunmamaktadır. Bu olgu sunumunda antifosfolipid antikor sendromu zemininde BCS gelişen gebe olgusu bildirilmiştir.
Dergititle.paper.fact_presentationErişime Açık
  • 1. Aydinli M, Bayraktar Y. Budd-Chiari syndrome: Etiology, pathogenesis and diagnosis. World J Gastroenterol. 2007;13 (19):2693–6.
  • 2. Rautou PE, Angermayr B, Garcia-Pagan JC, Moucari R, Peck-Radosavljevic M, Raffa S, et al. Pregnancy in women with known and treated Budd-Chiari syndrome: Maternal and fetal outcomes. J Hepatol. 2009;
  • 3. Khuroo MS, Datta D V. Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract. Am J Med. 1980;
  • 4. Türk Cerrahi Derneği. Gastrointestinal Sistem Endoskopisi. 2016.
  • 5. Grus T, Lambert L, Grusová G, Banerjee R, Burgetová A. Budd-Chiari Syndrome. Prague Med Rep. 2017;
  • 6. Ren W, Li X, Jia J, Xia Y, Hu F, Xu Z. Prevalence of budd-chiari syndrome during pregnancy or puerperium: A systematic review and meta-analysis. Gastroenterol Res Pract. 2015;2015.
  • 7. Espinosa G, Font J, García-Pagan JC, Tàssies D, Reverter JC, Gaig C, et al. BuddChiari syndrome secondary to antiphospholipid syndrome: Clinical and immunologic characteristics of 43 patients. Medicine (Baltimore). 2001;80 (6):345–54.
  • 8. Merz WM, Rüland AM, Hippe V, Poetzsch B, Meyer C, Pollok JM, et al. Pregnancy in Budd-Chiari Syndrome: Case Report and Proposed Risk Score. Medicine (Baltimore). 2016;
  • 9. Dilawari JB, Bambery P, Chawla Y, Kaur U, Bhusnurmath SR, Malhotra HS, et al. Hepatic outflow obstruction (budd-chiari syndrome): Experience with 177 patients and a review of the literature. Med (United States). 1994; 73;21-36
  • 10. Khan F, Rowe I, Martin B, Knox E, Johnston T, Elliot C, et al. Outcomes of pregnancy in patients with known Budd-Chiari syndrome. World J Hepatol. 2017;
  • 11. Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut. 2006;
  • 12. Qi X, Ren W, Wang Y, Guo X, Fan D. Survival and prognostic indicators of BuddChiari syndrome: A systematic review of 79 studies. Expert Review of Gastroenterology and Hepatology. 2015.
  • 13. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J. 1997;
  • 14. Ramsey PS, Hay JE, Ramin KD. Successful pregnancy following orthotopic liver transplantation for idiopathic budd-chiari syndrome. J Matern Neonatal Med. 1998;
  • 15. Aggarwal N, Suri V, Chopra S, Sikka P, Dhiman RK, Chawla YK. Pregnancy outcome in Budd Chiari Syndrome-a tertiary care centre experience. Arch Gynecol Obstet. 2013;
  • 16. Segal S, Shenhav S, Segal O, Zohav E, Gemer O. Budd-Chiari syndrome complicating severe preeclampsia in a parturient with primary antiphospholipid syndrome. Eur J Obstet Gynecol Reprod Biol. 1996;
  • 17. Pati S, Bhattacharya S, Rakshit VM. Pregnancy complicated by Budd-Chiari syndrome and antiphospholipid syndrome. J Obstet Gynaecol (Lahore). 2009;
  • 18. Joffe GM, Aisenbrey GA, Argubright KF. Budd-chiari syndrome, systemic lupus erythematosus, and secondary antiphospholipid antibody syndrome in pregnancy. Obstet Gynecol. 2005;
  • 19. Polzin WJ, Kopelman JN, Robinson RD, Read JA, Brady K. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction. Obstet Gynecol. 1991;
  • 20. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.